Company
Monteris Medical
Summary
- Plymouth, United States
- Founded: 1999
- Stage: Startup
- Use: Civil
- Focus: Hardware-first
Fields
About
Makes the NeuroBlate System, a robotic MR-guided laser ablation tool used for brain tumors, radiation necrosis, and drug-resistant epilepsy.
Funding
- Total raised
- At least $131.8M
- Newest round
- Debt Refin. · $38M27 Oct 2022
- Led by
- Madryn Asset Management
| Investor | Rounds |
|---|---|
| BDC | Seed, Series C ExtensionLead, Venture RoundLead, Series BLead, Series CLead, Series DLead, Venture RoundLead, Venture RoundLead |
| Oxford Finance LLC | Series C Extension, Venture Round, Series B, Series C, Series D, Venture Round, Venture Round |
| Southwest Michigan First | Series C Extension, Venture Round, Series B, Series C, Series D, Venture Round, Venture Round |
| Birchview Capital | Series ELead, Series C, Series D |
| InnovaHealth Partners, LP | Series ELead, Series DLead |
| Madryn Asset Management | Series E, Debt Refin.Lead |
| CU Healthcare Innovation Fund | Series E |
| OSF Ventures | Series E |
| OSF HealthCare | Series E |
| BDC Healthcare Venture | Series B |
| The Vertical Group | Series B |
| Tony Chou | Series B |
| Versant Ventures | Series CLead |
| SightLine Partners | Series CLead |
Aviato · checked 12 Oct 2026
Machines
1On the map
Sources
20Official filings18
FDA 510(k) clearance K262315: NeuroBlate System
U.S. FDA3 Sept 2026FDA 510(k) clearance K260976: NeuroBlate System
U.S. FDA23 Apr 2026FDA 510(k) clearance K240877: Monteris Medical NeuroBlate System
U.S. FDA4 Jun 2024FDA 510(k) clearance K231061: NeuroBlate System
U.S. FDA8 Dec 2023FDA 510(k) clearance K222983: NeuroBlate Fusion-S Software V3.17
U.S. FDA15 Mar 2023
13 older official filings
FDA 510(k) clearance K201056: NeuroBlate System
U.S. FDA21 Aug 2020FDA 510(k) clearance K193375: NeuroBlate System
U.S. FDA3 Jan 2020FDA 510(k) clearance K182036: NeuroBlate System
U.S. FDA15 Oct 2018FDA 510(k) clearance K173305: NeuroBlate System
U.S. FDA17 Nov 2017FDA 510(k) clearance K172881: NeuroBlate System
U.S. FDA20 Oct 2017FDA 510(k) clearance K171255: Monteris Medical NeuroBlate System
U.S. FDA25 Jul 2017FDA 510(k) clearance K170724: NeuroBlate System
U.S. FDA7 Apr 2017FDA 510(k) clearance K162762: NeuroBlate System
U.S. FDA26 Oct 2016FDA 510(k) clearance K143457: NeuroBlate System
U.S. FDA19 Feb 2015FDA 510(k) clearance K141983: NEUROBLATE SYSTEM
U.S. FDA11 Aug 2014FDA 510(k) clearance K131955: NEUROBLATE(TM) SYSTEM
U.S. FDA30 Jul 2013FDA 510(k) clearance K131278: MONTERIS MEDICAL NEUROBLATE SYSTEM
U.S. FDA11 Jul 2013FDA 510(k) clearance K120561: NEUROBLATE SYSTEM
U.S. FDA1 Apr 2013
Company claims2
Monteris Medical about NeuroBlate® System: "For purchase orders, contact your Monteris representative."
monteris.comUndatedMonteris Medical names NeuroBlate® System on its website.
monteris.comUndated
Monteris Medical
1 machine on robomap
